The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
May 10th 2024
A Veterans Affairs study finds low alpha-1 antitrypsin phenotyping rates, indicating the need for improved healthcare provider education on AATD.
The pundits are going to have their field day with this one. "The danger [with this Bill] is that as costs continue to rise and coverage becomes less comprehensive, people will conclude that we've tried health reform and it didn't work. But the real problem will be that we didn't really try it.
Obama Discusses Preventative Screening Tests for Colorectal Cancer
September 15th 2009President Obama addressed his goal to cover preventative screening tests last week saying that there is "no reason" for cancers, such as breast and colon, not to be caught before they become advanced, and bringing to attention the efforts of government officials to have these screening tests covered by public and private insurance companies.
New Therapy for Barrett's Esophagus and Prevention of Esophageal Adenocarcinoma
As you may know, in about 10% of people, the natural history of GERD is progression to Barrett's esophagus, where the normal squamous epithelial lining of the esophagus is displaced by columnar epithelium from the intestine (intestinal metaplasia).
FDA now Requires Stronger Warning Labels for Tumor-necrosis Factor-alpha Blockers
August 21st 2009The FDA is now requiring that stronger product warnings be included in the prescribing information of tumor necrosis factor-alpha blockers because of an increased risk of cancer in the children and adolescents who take them.
Healthy Patients Treated with Proton Pump Inhibitors May Develop Dependency
July 7th 2009A new study has found that treating patients with proton pump inhibitors for eight weeks “induces acid-related symptoms like heartburn, acid regurgitation and dyspepsia” after healthy patients were no longer receiving the treatment.